QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 15 January 2008
doi: 10.1242/jcs.022566

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.022566v1 121/3/282    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoon, M.-S. Articles by Chen, J. Search for Related Content PubMed PubMed Citation Articles by Yoon, M.-S. Articles by Chen, J. Social Bookmarking                         What's this?

PLD regulates myoblast differentiation through the mTOR-IGF2 pathway

Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Avenue B107, Urbana, IL 61801, USA

^* Author for correspondence (e-mail: jiechen{at}uiuc.edu)

Accepted 7 November 2007

A mammalian target of rapamycin (mTOR) pathway is essential for the differentiation of cultured skeletal myoblasts in response to growth factor withdrawal. Previously, phospholipase D (PLD) has been found to play a role in cell growth regulation and mitogenic activation of mTOR signaling. However, a role for PLD in the autocrine regulation of myoblast differentiation is not known. Here we show that upon induction of differentiation in mouse C2C12 satellite cells, the expression of both PLD1 and PLD2 is upregulated. C2C12 differentiation is markedly inhibited by 1-butanol, an inhibitor of the PLD-catalyzed transphosphatidylation reaction, and also by the knockdown of PLD1, but not PLD2. Further investigation has revealed that PLD1 is unlikely to regulate myogenesis through modulation of the actin cytoskeleton as previously suggested. Instead, PLD1 positively regulates mTOR signaling leading to the production of IGF2, an autocrine factor instrumental for the initiation of satellite cell differentiation. Furthermore, exogenous IGF2 fully rescues the differentiation defect resulting from PLD1 knockdown. Hence, PLD1 is critically involved in skeletal myogenesis by regulating the mTOR-IGF2 pathway.

Key words: mTOR, Myogenesis, Phospholipase D (PLD)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G.-H. Liu, T. Guan, K. Datta, J. Coppinger, J. Yates III, and L. Gerace Regulation of Myoblast Differentiation by the Nuclear Envelope Protein NET39 Mol. Cell. Biol., November 1, 2009; 29(21): 5800 - 5812. [Abstract] [Full Text] [PDF]

				C. R. Geest, F. J. Zwartkruis, E. Vellenga, P. J. Coffer, and M. Buitenhuis Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells Haematologica, July 1, 2009; 94(7): 901 - 910. [Abstract] [Full Text] [PDF]

				Y. Sun, Y. Fang, M.-S. Yoon, C. Zhang, M. Roccio, F. J. Zwartkruis, M. Armstrong, H. A. Brown, and J. Chen Phospholipase D1 is an effector of Rheb in the mTOR pathway PNAS, June 17, 2008; 105(24): 8286 - 8291. [Abstract] [Full Text] [PDF]